Acceleron Pharma competitors

Acceleron Pharma's competitors include XOMA, Novartis, Rigel Pharmaceuticals and GlaxoSmithKline
Add company...
Acceleron Pharma
Acceleron is a biopharmaceutical company engaged in developing, manufacturing and commercializing novel biotherapeutics.
XOMA
XOMA is a biotechnology company discovering, developing and commercializing antibody-based therapeutics.
Novartis
Novartis researches, develops, manufactures, and markets a range of healthcare products.
Rigel Pharmaceuticals
Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.
GlaxoSmithKline
GlaxoSmithKline is a science-led healthcare company.
Founding Date
Founding Date
2003
Founding Date
1981
Founding Date
1996
Founding Date
1996
Founding Date
2000
Type
Type
Public
Type
Public
Type
Public
Type
Public
Type
Public
Tags
Locations
Locations
Cambridge, US HQ
Locations
Emeryville, US HQ
Locations
Basel, CH HQ
Núñez, AR
Elsene, BE
São Paulo, BR
Dorval, CA
Chaoyang Qu, CN
Praha 4, CZ
see more
Locations
South San Francisco, US HQ
Locations
Brentford, GB HQ
Employees
Employees
121
Employees
1878% decrease
Employees
126,0004% increase
Employees
77
Employees
98,462
Valuation ($)
Valuation ($)
2.7 b
Valuation ($)
137.9 m
Valuation ($)
175.5 b
Valuation ($)
552.6 m
Valuation ($)
101.9 b
Facebook likes
Facebook likes
N/A
Facebook likes
N/A
Facebook likes
304.3 k
Facebook likes
1.1 k
Facebook likes
273 k
Twitter followers
Twitter followers
499
Twitter followers
185
Twitter followers
234.4 k
Twitter followers
1.3 k
Twitter followers
163.4 k

Financial

Revenue (est.)
Revenue (est.)
$13.5m (FY, 2017)
Revenue (est.)
$52.7m (FY, 2017)
Revenue (est.)
$49.1b (FY, 2017)
Revenue (est.)
N/A
Revenue (est.)
£30.2b (FY, 2017)
Cost of goods
Cost of goods
N/A
Cost of goods
N/A
Cost of goods
$17.2b (FY, 2017)
Cost of goods
N/A
Cost of goods
£10.3b (FY, 2017)
Gross profit
Gross profit
N/A
Gross profit
N/A
Gross profit
$31.9b (FY, 2017)
Gross profit
N/A
Gross profit
£19.8b (FY, 2017)
Net income
Net income
($108.5m) (FY, 2017)
Net income
N/A
Net income
$7.7b (FY, 2017)
Net income
($78m) (FY, 2017)
Net income
£2.2b (FY, 2017)

Operating

Phase III Trials Products
Phase III Trials Products
2 (FY, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
29 (Y, 2016)
Phase III Trials Products
N/A
Phase III Trials Products
N/A

Funding

Total funding raised
Total funding raised
$ 122.8m
Total funding raised
N/A
Total funding raised
$ 6.5m
Total funding raised
$ 130m
Total funding raised
N/A
For sources of this data, please see the company profileDownload Excel

View company profiles

XOMA
HQ
Emeryville, US
Employees
18

XOMA is a biotechnology company discovering, developing and commercializing antibody-based therapeutics.

View company
Novartis
HQ
Basel, CH
Employees
126,000↑ 4% increase

Novartis researches, develops, manufactures, and markets a range of healthcare products.

View company
Rigel Pharmaceuticals
HQ
South San Francisco, US
Employees
77

Rigel Pharmaceuticals develops small-molecule drugs for the treatment of autoimmune diseases, cancer and metabolic diseases.

View company
GlaxoSmithKline
HQ
Brentford, GB
Employees
98,462

GlaxoSmithKline is a science-led healthcare company.

View company